Literature DB >> 3352920

Multiple sclerosis in Saudi Arabia.

B A Yaqub1, A K Daif.   

Abstract

There are indications of increasing incidence of MS in Saudi Arabia. Of 806 neurology inpatients, 16 had MS, 21 myasthenia gravis, and 10 amyotrophic lateral sclerosis, with a ratio of 1:1.3:0.6, respectively. The symptomatology and site of lesions are similar to that seen in the West, but the course and evolution might be different. The main course was remissions and relapses but without transformation to chronic progressive disease, and the main disability was partial or complete bilateral visual loss, seen in 19% of the patients.

Entities:  

Mesh:

Year:  1988        PMID: 3352920     DOI: 10.1212/wnl.38.4.621

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  The food pattern in geographical relation to the risk of multiple sclerosis in the Mediterranean and Near East region.

Authors:  K Lauer
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

2.  Multiple sclerosis in Jordan: A clinical and epidemiological study.

Authors:  Khalid El-Salem; Ehsan Al-Shimmery; Khalid Horany; Ali Al-Refai; Kefah Al-Hayk; Yousef Khader
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

3.  The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients.

Authors:  D Montanaro; V Sanna; G Matarese; B B Larby; L Racioppi; P B Carrieri; R Bruno; N J Davey; S Zappacosta; S Fontana
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 4.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Stroke and seizure continue to be the major brunt of in patient neurology care. An observation from teaching hospital.

Authors:  Azra Zafar; Majed Alabdali; Rizwana Shahid; Danah Aljaafari; Fahd A Al-Khamis; Aishah I Albakr; Saima Nazish; Abdulla A Al-Sulaiman; Alon Abraham
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

6.  Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia.

Authors:  S Khan; B A Yaqub; C M Poser; S M al Deeb; S Bohlega
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

7.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Authors:  A Valli; A Sette; L Kappos; C Oseroff; J Sidney; G Miescher; M Hochberger; E D Albert; L Adorini
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia.

Authors:  Saima Nazish; Rizwana Shahid; Azra Zafar; Foziah Alshamrani; Abdullah Al Sulaiman; Majed Alabdali; Danah Aljaafari; Esraa Al Wabari; Fahd A Alkhamis
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

9.  Assessment of safety and effectiveness of oral multiple sclerosis medication.

Authors:  Abdulrahman M Al Turaiki; Maha A Al Ammari; Dalal A Alabdulkarim; Abdullah U Althemery
Journal:  Saudi Med J       Date:  2019-11       Impact factor: 1.484

Review 10.  Multiple sclerosis in the Arabian Gulf countries: a consensus statement.

Authors:  Saeed Bohlega; Jihad Inshasi; Abdel Rahman Al Tahan; Abu Bakr Madani; Hussien Qahtani; Peter Rieckmann
Journal:  J Neurol       Date:  2013-03-17       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.